METOCLOPRAMIDE hydrochloride
- Product NDC
- 40032-580
- 11-digit product format
- 400320580
- Labeler code
- 40032
- Product ID
- 40032-580_6560c273-018b-4668-8c95-f5fd1fe77998
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- Metoclopramide Hydrochloride
- Dosage form
- TABLET, ORALLY DISINTEGRATING
- Route
- ORAL
- Labeler
- Novel Laboratories, Inc.
- Application
- ANDA202191
- Marketing category
- ANDA
- Marketing start
- 2014-08-15
- Marketing end
- 0000-00-00
- Substance
- METOCLOPRAMIDE HYDROCHLORIDE
- Active strength
- 10 mg/1
- Pharmacologic classes
- Dopamine D2 Antagonists [MoA],Dopamine-2 Receptor Antagonist [EPC]
- NDC exclude flag
- No
- Listing certified through
- 2019-12-31
- Current FDA listing
- Historical FDA.report record
NDC auxiliary status#
These records are reproduced from FDA’s unfinished, excluded, and compounder listings. They describe what appeared in the source files; a missing record does not establish a regulatory status. View all current auxiliary records, including entries without an NDC. · View the auxiliary file history.
| Dataset | Scope | Product NDC | Package NDC | Code | Status | Reporting period | Source date |
|---|---|---|---|---|---|---|---|
| excluded product | product | 40032-580 | I | Inactivated by FDA | 2026-08-11 | ||
| excluded package | package | 40032-580 | 40032-580-31 | I | Inactivated by FDA | 2026-08-11 |
Observed NDC auxiliary status history#
This history shows the information present in each captured FDA auxiliary file. It is not a continuous regulatory timeline, and a missing record does not establish a status.
| Captured / source date | Dataset | Scope | Package NDC | Snapshot | Source SHA-256 |
|---|---|---|---|---|---|
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded product | product | d630ba8d3edf… | 732f749b63fb… | |
| 2025-12-14 17:58 UTC · source 2025-12-05 | excluded package | package | 40032-580-31 | d630ba8d3edf… | 732f749b63fb… |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded product | product | f5e01cc5f278… | a2eaf40c39c3… | |
| 2025-08-27 00:01 UTC · source 2025-08-26 | excluded package | package | 40032-580-31 | f5e01cc5f278… | a2eaf40c39c3… |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded product | product | 2ef7874e63bc… | 57b86245f4fa… | |
| 2025-04-01 02:39 UTC · source 2025-03-31 | excluded package | package | 40032-580-31 | 2ef7874e63bc… | 57b86245f4fa… |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded product | product | a1b67e2a42f9… | c4cf2c586c0d… | |
| 2025-03-28 20:22 UTC · source 2025-03-28 | excluded package | package | 40032-580-31 | a1b67e2a42f9… | c4cf2c586c0d… |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded product | product | cfe11265f3b6… | 090c488252e2… | |
| 2025-03-22 03:12 UTC · source 2025-03-21 | excluded package | package | 40032-580-31 | cfe11265f3b6… | 090c488252e2… |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded product | product | cdf11ea48f46… | ba0047e9e063… | |
| 2025-03-10 12:48 UTC · source 2025-03-10 | excluded package | package | 40032-580-31 | cdf11ea48f46… | ba0047e9e063… |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded product | product | 302b2466d912… | e7b80fea0513… | |
| 2025-02-02 03:52 UTC · source 2025-01-31 | excluded package | package | 40032-580-31 | 302b2466d912… | e7b80fea0513… |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded product | product | ed331223b511… | 672a5bd82f5f… | |
| 2025-01-20 13:05 UTC · source 2025-01-20 | excluded package | package | 40032-580-31 | ed331223b511… | 672a5bd82f5f… |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded product | product | 0efc9e666f02… | f202fb6c5f17… | |
| 2025-01-11 03:41 UTC · source 2025-01-10 | excluded package | package | 40032-580-31 | 0efc9e666f02… | f202fb6c5f17… |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded product | product | ad56d346431e… | cc804d4bbf1e… | |
| 2024-11-09 02:27 UTC · source 2024-11-08 | excluded package | package | 40032-580-31 | ad56d346431e… | cc804d4bbf1e… |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded product | product | 367a005e9d99… | 383a685ebd0f… | |
| 2024-10-04 04:10 UTC · source 2024-10-03 | excluded package | package | 40032-580-31 | 367a005e9d99… | 383a685ebd0f… |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded product | product | 557ba5c1ecfa… | 9c80585c8c6e… | |
| 2024-07-10 04:00 UTC · source 2024-07-09 | excluded package | package | 40032-580-31 | 557ba5c1ecfa… | 9c80585c8c6e… |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded product | product | 8af77b9d5b6f… | d9bbb34c5368… | |
| 2024-05-28 21:12 UTC · source 2024-05-28 | excluded package | package | 40032-580-31 | 8af77b9d5b6f… | d9bbb34c5368… |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded product | product | 834df4deac94… | adcc014656a3… | |
| 2024-05-15 03:39 UTC · source 2024-05-14 | excluded package | package | 40032-580-31 | 834df4deac94… | adcc014656a3… |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded product | product | 1332a3947898… | d4bfe170f9cd… | |
| 2024-03-11 06:39 UTC · source 2024-03-08 | excluded package | package | 40032-580-31 | 1332a3947898… | d4bfe170f9cd… |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded product | product | fb8cb913e6d1… | eb8c232b6be0… | |
| 2022-08-30 03:57 UTC · source 2022-08-29 | excluded package | package | 40032-580-31 | fb8cb913e6d1… | eb8c232b6be0… |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded product | product | 86f5da6cb304… | a595104c45d7… | |
| 2022-04-09 23:13 UTC · source 2022-04-08 | excluded package | package | 40032-580-31 | 86f5da6cb304… | a595104c45d7… |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded product | product | bd6a592717d7… | 303034d00443… | |
| 2022-04-04 05:40 UTC · source 2022-04-01 | excluded package | package | 40032-580-31 | bd6a592717d7… | 303034d00443… |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded product | product | 8dfbde2a14a4… | c9ff85d89658… | |
| 2021-12-27 23:28 UTC · source 2021-12-27 | excluded package | package | 40032-580-31 | 8dfbde2a14a4… | c9ff85d89658… |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded product | product | e2bbac7714bc… | 27bdfed8d636… | |
| 2020-12-18 03:04 UTC · source 2020-12-17 | excluded package | package | 40032-580-31 | e2bbac7714bc… | 27bdfed8d636… |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded product | product | 9bebd1f3094a… | 5416666fcb17… | |
| 2020-06-10 20:45 UTC · source 2020-06-10 | excluded package | package | 40032-580-31 | 9bebd1f3094a… | 5416666fcb17… |
Orange Book products#
| Application-product | Trade name | Ingredient | Strength | Dosage form / route | TE codes | RLD / RS | Approval date |
|---|---|---|---|---|---|---|---|
| A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | ||
| A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 |
Observed Orange Book product history#
Observed FDA ZIP history: Each table is queried independently by exact application/product key from successfully parsed Orange Book snapshots. Capture times identify archived source observations; absence or a change between snapshots is not inferred. FDA publication files that were not recoverable as structured ZIP data are not represented as states.
| Captured | Edition | Application-product | Trade name | Strength | Dosage form / route | Product TE source text | RLD / RS | Approval date | Source SHA-256 |
|---|---|---|---|---|---|---|---|---|---|
| 2026-02-19 14:30 UTC | 2026-02 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 011fe1cb6892… | ||
| 2026-02-19 14:30 UTC | 2026-02 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 011fe1cb6892… | |
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 31067a03dcf5… | ||
| 2025-12-14 10:44 UTC · 2 captures of this ZIP | 2025-12 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 31067a03dcf5… | |
| 2025-08-23 18:47 UTC | 2025-08 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 6a471c1ec25d… | ||
| 2025-08-23 18:47 UTC | 2025-08 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 6a471c1ec25d… | |
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | fd3edfee7708… | ||
| 2025-03-22 03:13 UTC · 3 captures of this ZIP | 2025-03 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | fd3edfee7708… | |
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | b8a1b40f171c… | ||
| 2025-02-26 10:13 UTC · 3 captures of this ZIP | 2025-02 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | b8a1b40f171c… | |
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 03ed91905a0d… | ||
| 2025-01-19 17:59 UTC · 7 captures of this ZIP | 2025-01 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 03ed91905a0d… | |
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 2680178bc6a6… | ||
| 2024-12-13 21:23 UTC · 2 captures of this ZIP | 2024-12 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 2680178bc6a6… | |
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 5bbf6a4d5a75… | ||
| 2024-09-14 05:58 UTC · 2 captures of this ZIP | 2024-09 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 5bbf6a4d5a75… | |
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | d8e5a09893c0… | ||
| 2024-11-08 22:44 UTC · 3 captures of this ZIP | 2024-11 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | d8e5a09893c0… | |
| 2024-10-29 15:01 UTC | 2024-10 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | d06236e962d9… | ||
| 2024-10-29 15:01 UTC | 2024-10 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | d06236e962d9… | |
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 79d66fd596c7… | ||
| 2024-08-13 05:28 UTC · 3 captures of this ZIP | 2024-08 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 79d66fd596c7… | |
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 301d65b070ca… | ||
| 2024-07-13 05:37 UTC · 2 captures of this ZIP | 2024-07 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 301d65b070ca… | |
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 1e350fbaab3a… | ||
| 2024-06-18 03:08 UTC · 5 captures of this ZIP | 2024-06 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 1e350fbaab3a… | |
| 2024-05-31 18:47 UTC | 2024-05 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 8072bd15b7f6… | ||
| 2024-05-31 18:47 UTC | 2024-05 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 8072bd15b7f6… | |
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 5c6f7cd8ea54… | ||
| 2022-06-29 02:47 UTC · 2 captures of this ZIP | 2022-06 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 5c6f7cd8ea54… | |
| 2022-04-08 23:34 UTC | 2022-04 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 5d02ea3f76ae… | ||
| 2022-04-08 23:34 UTC | 2022-04 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 5d02ea3f76ae… | |
| 2022-04-04 05:41 UTC | 2022-04 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 4b0b4de00fa7… | ||
| 2022-04-04 05:41 UTC | 2022-04 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 4b0b4de00fa7… | |
| 2019-12-13 00:20 UTC | 2019-12 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 74a2ff9319b5… | ||
| 2019-12-13 00:20 UTC | 2019-12 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 74a2ff9319b5… | |
| 2022-03-09 01:35 UTC | 2022-03 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | bb7c543d1eb4… | ||
| 2022-03-09 01:35 UTC | 2022-03 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | bb7c543d1eb4… | |
| 2021-12-28 21:50 UTC | 2021-12 | A202191-001 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 5MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | 2014-08-15 | 782e0a99824c… | ||
| 2021-12-28 21:50 UTC | 2021-12 | A202191-002 | METOCLOPRAMIDE HYDROCHLORIDE | EQ 10MG BASE | TABLET, ORALLY DISINTEGRATING / ORAL | RS | 2014-08-15 | 782e0a99824c… |
DailyMed Product Concepts#
| Product concept | Relation | Version | Effective |
|---|---|---|---|
| a62a50ac-1535-4461-9768-8ae703e2e9fb | Product name | 1 | 20210525 |
| 86441fd8-22b8-41db-bb26-c70dffc3923b | Product name | 1 | 20210111 |
| 340a6817-217a-4b71-9e83-8e2e60c4b0c5 | Product name | 1 | 20150319 |
| 1f2c49ec-0a44-8021-ecde-b27ece080b13 | Product name | 1 | 20140508 |
| 46471181-3fa6-5fcd-1d9f-1bb9d2b06171 | Product name | 1 | 20140508 |
| 9514609b-a2a9-f8ec-6ba6-3f8e5ee89877 | Product name | 1 | 20140508 |
| bc07ef78-e82d-0c19-31f4-31f263780582 | Product name | 1 | 20140508 |
FDA-Initiated Inactive NDC Indexing#
| NDC | Effective | Action | Document | Indexing SPL | Related label |
|---|---|---|---|---|---|
| 40032-580-31 | 2020-01-31 | C162847 | 48780-1 | 9d75b9d0-f445-f424-e053-dadaa90a57ce | These highlights do not include all the information needed to use METOCLOPRAMIDE hydrochloride safely and effectively. See full prescribing information for METOCLOPRAMIDE hydrochloride. METOCLOPRAMIDE hydrochloride (Metoclopramide Hydrochloride) TABLET, ORALLY DISINTEGRATING for ORAL use. Initial U.S. Approval: 1976 |
DailyMed Package Descriptions#
| Package NDC | Product | Description | Form | Quantity | Strength | SPL version |
|---|---|---|---|---|---|---|
| 40032-580-31 | METOCLOPRAMIDE hydrochloride | 10 in 1 BLISTER PACK | TABLET, ORALLY DISINTEGRATING | 10 | 6 | |
| 40032-580-31 | METOCLOPRAMIDE hydrochloride | 10 in 1 CARTON | TABLET, ORALLY DISINTEGRATING | 10 | 6 |
DailyMed Socrata Ingredients#
DailyMed Dashboard NDC Coverage#
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| METOCLOPRAMIDE hydrochloride | METOCLOPRAMIDE HYDROCHLORIDE | Lupin Pharmaceuticals,Inc. | 7cd1dc35-2fb2-4f1d-8769-24c3c3aa34fa | 2020-12-02 | Boxed warning, Warnings, Adverse reactions | 202191 ANDA202191 |
DailyMed RxNorm Mappings#
| RxCUI | RxNorm string | TTY | DailyMed | SPL version |
|---|---|---|---|---|
| 608623 | metoclopramide HCl 10 MG Disintegrating Oral Tablet | PSN | 3fb9a45e-48ba-45c5-86a7-03a8744888f6 | 6 |
| 608624 | metoclopramide HCl 5 MG Disintegrating Oral Tablet | PSN | 3fb9a45e-48ba-45c5-86a7-03a8744888f6 | 6 |
| 608623 | metoclopramide 10 MG Disintegrating Oral Tablet | SCD | 3fb9a45e-48ba-45c5-86a7-03a8744888f6 | 6 |
| 608624 | metoclopramide 5 MG Disintegrating Oral Tablet | SCD | 3fb9a45e-48ba-45c5-86a7-03a8744888f6 | 6 |
| 608623 | metoclopramide 10 MG (metoclopramide hydrochloride 11.82 MG) Disintegrating Oral Tablet | SY | 3fb9a45e-48ba-45c5-86a7-03a8744888f6 | 6 |
| 608624 | metoclopramide 5 MG (as metoclopramide HCl 5.91 MG) Disintegrating Oral Tablet | SY | 3fb9a45e-48ba-45c5-86a7-03a8744888f6 | 6 |
Packages#
| Package NDC | 11-digit format | Description | Status |
|---|---|---|---|
| 40032-580-31 | 40032058031 | 10 in 1 BLISTER PACK | Historical |